JABIL ALERT: Bragar Eagel & Squire, P.C. is Investigating Jabil Inc. on Behalf of Jabil Stockholders and Encourages Investors to Contact the Firm
03 mai 2024 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, May 03, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Jabil Inc. (“Jabil” or the...
EQUINIX ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Equinix and Encourages Investors to Contact the Firm
03 mai 2024 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, May 03, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Equinix...
POET Announces Closing of CAD$10 Million Non-brokered Financing with a Single Institutional Investor
03 mai 2024 11h45 HE
|
POET Technologies Inc.
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, May 03, 2024 (GLOBE NEWSWIRE) -- POET Technologies Inc. (“POET” or the “Company”) (TSX Venture:...
Augmedix to Participate in Upcoming Investor Conferences in May and June 2024
03 mai 2024 07h00 HE
|
Augmedix Inc
SAN FRANCISCO, May 03, 2024 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today announced that its management team will...
AvePoint to Participate in Upcoming Investor Conferences
02 mai 2024 16h05 HE
|
AvePoint, Inc.
JERSEY CITY, N.J., May 02, 2024 (GLOBE NEWSWIRE) -- AvePoint (Nasdaq: AVPT), the most advanced platform to optimize SaaS operations and secure collaboration, today announced that members of the...
Telos Corporation to Participate in Upcoming Investor Conferences
02 mai 2024 08h33 HE
|
Telos Corporation
ASHBURN, Va., May 02, 2024 (GLOBE NEWSWIRE) -- Telos Corporation (NASDAQ: TLS), a leading provider of cyber, cloud and enterprise security solutions for the world’s most security-conscious...
Palisade Bio Announces $4 Million Private Placement Priced At-The- Market Under Nasdaq Rules
02 mai 2024 08h30 HE
|
Palisade Bio, Inc.
Carlsbad, CA, May 02, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI), a biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with...
Alterra IOS Venture III raises $925 million, surpassing $750 million target and increasing hard cap beyond $850 million
02 mai 2024 08h00 HE
|
Park Madison Partners
Alterra Property Group, LLC announces final close of oversubscribed Alterra IOS Venture III. Park Madison Partners served as the exclusive placement agent
PROPHASE LABS INC. TO PRESENT FIRST QUARTER 2024 FINANCIAL RESULTS ON MAY 9
02 mai 2024 08h00 HE
|
ProPhase Labs, Inc.
GARDEN CITY, NY, May 02, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), announced today that they will be presenting first quarter 2024 financial results on a virtual conference call...
Athira Pharma to Participate in Upcoming May Conferences
02 mai 2024 07h00 HE
|
Athira Pharma, Inc.
BOTHELL, Wash., May 02, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health...